The anti-C5a antibody vilobelimab efficiently inhibits C5a in severe COVID-19 patients

Vlaar, APJ; van de Beek, D; Pilz, K; Xu, ZL; Habel, M; Guo, R; Riedemann, NC

MOLECULAR IMMUNOLOGY, 2022; 141 (): 222

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索